Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ulmus pumila pollen
- Development stage
- Unknown
- Lead developer
- ALK Abelló
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intradermal, Epicutaneous
01
Overview
Ulmus pumila pollen is a non-standardized allergenic extract derived from the pollen of the Siberian or Chinese elm tree. It is a biologic product used for both the diagnosis and treatment of Type I hypersensitivity (allergies) to elm pollen. For diagnosis, it is administered via percutaneous (prick) or intradermal skin tests to identify sensitization. For treatment, it is used in allergen immunotherapy, administered via subcutaneous injections, to desensitize the immune system to the pollen allergens. This process aims to reduce the symptoms of allergic rhinitis and other related allergic conditions upon environmental exposure. The product is intended for use by physicians experienced in allergy care.
- Other names
- Chinese elm pollenSiberian elm pollenSiberian elm pollen extractUlmus pumila pollen extract
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on ulmus pumila pollen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ulmus pumila pollen.